PureTech Health Valuation
| PRTC Stock | USD 18.55 1.12 5.69% |
At this time, the company appears to be undervalued. PureTech Health PLC holds a recent Real Value of $26.44 per share. The prevailing price of the company is $18.55. Our model determines the value of PureTech Health PLC from analyzing the company fundamentals such as Return On Equity of 0.0642, shares outstanding of 24.03 M, and Operating Margin of (15.30) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting PureTech Health's valuation include:
Price Book 1.0747 | Enterprise Value | Enterprise Value Ebitda 2.562 | Price Sales 92.3097 | Trailing PE 8.8333 |
Undervalued
Today
Please note that PureTech Health's price fluctuation is very steady at this time. Calculation of the real value of PureTech Health PLC is based on 3 months time horizon. Increasing PureTech Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since PureTech Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PureTech Stock. However, PureTech Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 18.55 | Real 26.44 | Target 53.25 | Hype 18.54 | Naive 19.94 |
The real value of PureTech Stock, also known as its intrinsic value, is the underlying worth of PureTech Health PLC Company, which is reflected in its stock price. It is based on PureTech Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of PureTech Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of PureTech Health PLC helps investors to forecast how PureTech stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PureTech Health more accurately as focusing exclusively on PureTech Health's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use PureTech Health's intrinsic value based on its ongoing forecasts of PureTech Health's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against PureTech Health's closest peers. If more than one evaluation category is relevant for PureTech Health we suggest using both methods to arrive at a better estimate.
PureTech Health Cash |
|
PureTech Valuation Trend
Comparing PureTech Health's enterprise value against its market capitalization is a good way to estimate the value of PureTech Health PLC uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
PureTech Health Total Value Analysis
PureTech Health PLC is at this time anticipated to have valuation of 95.77 M with market capitalization of 445.67 M, debt of 22.36 M, and cash on hands of 368.03 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PureTech Health fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
95.77 M | 445.67 M | 22.36 M | 368.03 M |
PureTech Health Investor Information
The company has price-to-book ratio of 1.07. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PureTech Health PLC had not issued any dividends in recent years. PureTech Health PLC may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.PureTech Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. PureTech Health has an asset utilization ratio of 0.72 percent. This indicates that the Company is making $0.00716 for each dollar of assets. An increasing asset utilization means that PureTech Health PLC is more efficient with each dollar of assets it utilizes for everyday operations.PureTech Health Ownership Allocation
PureTech Health owns a total of 24.03 Million outstanding shares. Roughly 98.36 pct. of PureTech Health outstanding shares are held by general public with 1.64 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.PureTech Health Profitability Analysis
The company reported the previous year's revenue of 4.32 M. Net Income was 27.78 M with loss before overhead, payroll, taxes, and interest of (64.4 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates PureTech Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in PureTech Health and how it compares across the competition.
About PureTech Health Valuation
The stock valuation mechanism determines PureTech Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of PureTech Health. We calculate exposure to PureTech Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PureTech Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 4.3 M | 4.5 M | |
| Pretax Profit Margin | 5.51 | 5.79 | |
| Operating Profit Margin | (31.54) | (33.12) | |
| Net Profit Margin | 12.40 | 13.02 | |
| Gross Profit Margin | (0.55) | (0.58) |
PureTech Health Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 27 M | |
| Quarterly Earnings Growth Y O Y | 0.615 |
PureTech Health Current Valuation Indicators
Valuation refers to the process of determining the present value of PureTech Health PLC and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value PureTech we look at many different elements of the entity such as PureTech's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as PureTech Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use PureTech Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes PureTech Health's worth.Complementary Tools for PureTech Stock analysis
When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |